Why the War on Cancer Failed

Ignacio Castuera

American Journal of Economics and Sociology, 2022, vol. 81, issue 4, 671-700

Abstract: In 1971, President Nixon launched the “war on cancer” with great fanfare. The dramatic increase in spending on targeted cancer research was supposed to quickly yield new treatments. That did not happen. The cancer establishment, which profits from the $200 billion spent annually on cancer treatment, has never provided an adequate accounting of how more spending translates into lives saved. In fact, by the mid‐1980s, it became apparent that most of the “progress” in the war on cancer was little more than statistical sleight of hand. The death rate from cancer had climbed, not declined. Eventually, cancer deaths began to fall, but little of that improvement was due to better treatment. It was mostly a result of campaigns to reduce smoking and to promote early detection of treatable cancers. One reason the progress of treatment stalled was the unwillingness to consider unconventional treatments that were developed by doctors and other healers. Practitioners of unapproved treatments often sought refuge in Mexico from the medical apartheid system in the United States.

Date: 2022
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1111/ajes.12479

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bla:ajecsc:v:81:y:2022:i:4:p:671-700

Ordering information: This journal article can be ordered from
http://www.blackwell ... bs.asp?ref=0002-9246

Access Statistics for this article

American Journal of Economics and Sociology is currently edited by Laurence S. Moss

More articles in American Journal of Economics and Sociology from Wiley Blackwell
Bibliographic data for series maintained by Wiley Content Delivery ().